12-15 November, 2018
Marriott Marquis & Marina, San Diego, CA

Media Partners


Media Partners

ADC Review

ADC Society



ADC Review / Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international, peer-reviewed, online journal covering antibody-drug conjugates, biSpecific antibodies, site-specific antibody-drug conjugates, small-molecule drug conjugates and engineered fragments. We invite you to join our community of over 16,000 professionals in Large Drug Development (Pharma / Biotech), Small & Medium Drug Development, Equipment Manufacturers, Contract Development & Manufacturing Organizations, Regulatory & Government Agencies, Platform Technology and Academia. Visit us at

www.adcreview.comLinkedIn, Twitter and Vimeo



Antibodies is a relatively new journal with a major focus on quick dissemination of knowledge related to antibodies, especially how to quickly translate basic research results to therapeutic applications. Because it covers all areas related to antibodies unexpected connections between different areas could be made, leading to major discoveries and opening new fields of research and development.






Bentham Science

Bentham Science

Bioanalysis Zone


Bentham Science Publishers is a publishing company of scientific, technical, and medical literature based at Sharjah. Bentham publishes more than 116 subscription-based academic journals and over 230 open access journals and e-books.



Bioanalysis Zone is the online home of bioanalysis, binging together the latest news, views, research and products in one place. This free resource provides the ultimate one-stop shop for all busy bioanalysts to stay up-to-date in the fast moving field. Join us by visiting  http://www.bioanalysis-zone.com/register/.





Human Antibodies (IOS Press)

Media Partners: Human Antibodies

Biomedicines (ISSN 2227-9059) is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products, and is published quarterly online by MDPI with rapid publication. Biomedicines is covered by ESCI (Web of Science) and PubMed. Publication fees are fully waived for papers submitted in 2017.

Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications.





IOS Press

IJMS (ISSN 1422-0067) is an open access journal providing an advanced forum for biochemistry, molecular biology, pathology and toxicology, chemistry, material science and molecular physics (biological physicals, chemical physics and physical chemistry), and is published monthly online by MDPI with an average APT (article publishing time from submission to publication) of 60 days.


IOS Press serves the information needs of scientific and medical communities worldwide. IOS Press now publishes more than 100 international journals and approximately 100 book titles each year on subjects ranging from computer sciences and mathematics to medicine and the natural sciences


Life Science Network





Life Science Network is a relaxed forum in which thousands of life science executives, scientists, entrepreneurs, investors and media professionals can come together for easy communication, to make new connections, find new ways to collaborate, and help one another find the latest jobs or partnering opportunities.


Taylor & Francis, an academic publisher for two centuries, is committed to the publication of scholarly research. We publish the journal mAbs , which is a multi-disciplinary journal dedicated to the art and science of antibody research and development.



MabDesign Logo

 Medical News Today

MabDesign is a French non-profit membership organization that aims to federate, mobilize and support the development of the industrial sector in the field of immunotherapy.

MabDesign provides strategic leverage and development opportunities for its members, through the creation of a unique directory of stakeholders; by developing specialized training solutions, by providing business development and marketing support; as well as the organisation and support of scientific events, thus promoting networking and innovation.

MabDesign already counts with 115 + members companies, both pharmaceutical and biotechnology industries, service providers, training organizations and equipment suppliers at the front line of technology innovation.

Medical News Today has established itself as a market leader for medical news, providing concise and accurate information that stands out in the ocean of content that is health on the internet. The content is targeted to an educated audience of both healthcare professionals and patients.






Molecular and Cellular Oncology



PharmaVoice 140


Molecular and Cellular Oncology is a high-profile journal from Taylor & Francis for the publication of fundamental, translational and clinical research on cancer.





PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.


scidoc publishes

Scientia Pharmaceutica

SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals – Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications – online. Scientia Pharmaceutica – Official Organ of the Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG) – publishes original research papers, short communications and a limited number of reviews from all fields of pharmaceutical sciences and related disciplines, as well as from pharmaceutical practice.

Technology Networks

technology networks

 The Antibody Society


Technology Networks Group is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.



The Antibody Society is a non-profit association representing individuals and organizations involved in antibody research and development. We engage in activities that broadly benefit our members, such as education and publishing, and encourage collaboration between companies, academia and government organizations. We also help to organize conferences and networking events. As a trade association, the Society engages with government and international agencies to discuss issues of importance to the antibody community.www.antibodysociety.org


World ADC San Diego is open to press.

This year, we welcome accredited press to join World ADC San Diego to cover the very latest in new data, and fresh insights across the full ADC spectrum. With the largest single collection of ADC specialists, including 70 of the leading experts in the field speaking on the agenda, this is the meeting at which to discover the latest progress in the antibody drug conjugate field.

These complimentary press passes are limited. You will need to request a pass to gain approval from the meeting organizers. Press passes are only approved for press who intend to cover the meeting and are from the editorial team of your organization. Sales and marketing (or any other non editorial staff) will not be granted a press pass.

If you’d like to join us, simply email: adc@hansonwade.com. You will be sent a confirmation email upon approval. Please ensure you include your name, job title and company in your message.